Successful re-exposure to clozapine following uneventful rechallenge with olanzapine in a patient with neutropenia related to both agents

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 4, 2008, Pages 1089-1090

  Wu, Szu Ying ^a   Liu, Chen Chung ^a   Hsieh, Ming H ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; RISPERIDONE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW UP; HUMAN; LETTER; NEUTROPENIA; PARANOID SCHIZOPHRENIA; RECURRENT DISEASE;

EID: 42949159210     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.03.001     Document Type: Letter

References (10)

1. Alvir J.M. Lieberman J.A. Safferman A.Z. Schwimmer J.L. Schaaf J.A. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States N Engl J Med 329 1993 162 167
2. Benedetti F. Cavallaro R. Smeraldi E. Olanzapine-induced neutropenia after clozapine-induced neutropenia Lancet 354 1999 567
3. Duggal H.S. Gates C. Pathak P.C. Olanzapine-induced neutropenia: mechanism and treatment J Clin Psychopharmacol 24 2004 234 235
4. Dunk L.R. Annan L.J. Andrews C.D. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy Br J Psychiatry 188 2006 255 263
5. Flynn S.W. Altman S. MacEwan G.W. Black L.L. Greenidge L.L. Honer W.G. Prolongation of clozapine-induced granulocytopenia associated with olanzapine J Clin Psychopharmacol 17 1997 494 495
6. Gardner I. Zahid N. MacCrimmon D. Uetrecht J.P. A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes Mol Pharmacol 53 1998 991 998
7. Iverson S. Zahid N. Uetrecht J.P. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis Chem Biol Interact 142 2002 175 199
8. Sayin A. Cosar B. Prolongation of clozapine-induced leukopenia with olanzapine treatment Prog Neuropsychopharmacol Biol Psychiatry 30 2006 958 959
9. Thangadurai P. Jyothi K.S. Gopalakrishnan R. Kuruvilla A. Jacob K.S. Reversible neutropenia with olanzapine following clozapine-induced neutropenia Am J Psychiatry 163 2006 1298
10. Whiskey E. Taylor D. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities CNS Drugs 21 2007 25 35